ACBI1 Agonist A significant increase of the

A significant increase of the animal lifespan in the test groups (from 4

also known as RU-19110

Inhibitory effect of LY 255283 on the synthesis of leukotriene B(4) and thromboxane A(2) in human peripheral blood polymorphonuclear leukocytes and monocytes

Ocular hypotensive efficacy

leading to cell depolarization and increased excitability

ACBI1 Agonist A significant increase of theACBI1 is a potent PROTAC degrader of BAF ATPase subunits SMARCA2 and SMARCA4, also degrades the polybromo associated BAF (PBAF) complex member PBRM1, with DC50s of 6 nM, 11 nM and 32 nM for SMARCA2, SMARCA4 and PBRM1 in MV 4 11 cells, respectively. ACBI1 is composed of a bromodomain ligand, a linker, and the E3 ubiquitin ligase VHL. ACBI1 can induce anti proliferative effects and apoptosis. Product information CAS Number: 2375564 55 7 Molecular